Shanghai Henlius Biotech, Inc. - 2696.HK

2696.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
2696.HK	-0.1	-6.6	-20.5	-15.4	-15.4	40.7	-21.3	-54.4	-61.6	-61.6
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 2696.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	2696.HK
name	Shanghai Henlius Biotech, Inc.
price	19
changes percentage	-0.1052
change	-0.02
day low	18.96
day high	19.34
year high	23.95
year low	12.2
market cap	10326402492
price avg 50	22.014
price avg 200	20.96645
exchange	HKSE
volume	1031900
avg volume	421896
open	19
previous close	19.02
eps	1.35
pe	14.07
earnings announcement	2025-03-31T12:00:00.000+0000
shares outstanding	543494868
timestamp	2025-01-20 08:08:32

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 60.3%

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	5394909000	3214730000	67.82
gross profit	3918797000	2370109000	65.34
gross profit ratio	0.73	0.74	-1.48
research and development expenses	1118732000	1394514000	-19.78
operating expenses	3287093000	2728801000	20.46
interest income	8146000	3571000	128.12
interest expense	110539000	105672000	4.61
ebitda	911334000	-310612000	393.40
ebitdaratio	0.17	-0.1	275.76
operating income	631704000	-586577000	207.69
operating income ratio	0.12	-0.18	164.17
net income	546019000	-695259000	178.53
net income ratio	0.1	-0.22	146.80
eps	1	-1.28	178.13

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 5,395 million in 2023 from 3,215 million in 2022 representing a change of 67.82%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 3,919 million in 2023 from 2,370 million in 2022 representing a change of 65.34%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 911 million in 2023 from -311 million in 2022 representing a change of 393.4%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 632 million in 2023 from -587 million in 2022 representing a change of 207.69%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 546 million in 2023 from -695 million in 2022 representing a change of 178.53%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1 in 2023 from 1 in 2022 representing a change of 178.13%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 1,119 million in 2023 from 1,395 million in 2022 representing a change of -19.78%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 3,287 million in 2023 from 2,729 million in 2022 representing a change of 20.46%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	1373054500	1373054500	0.0
gross profit	995347500	995347500	0.0
gross profit ratio	0.72	0.72	0.0
research and development expenses	241233000	241233000	0.0
operating expenses	771315999	771315999	0.0
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	293174000	293174000	0.0
ebitdaratio	0.21	0.21	0.0
operating income	224031501	224031501	0.0
operating income ratio	0.16	0.16	0.0
net income	193150500	193150500	0.0
net income ratio	0.14	0.14	0.0
eps	0.36	0.36	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	9903571000	8924308000	10.97
total liabilities	7711270000	7287976000	5.81
total equity	2192301000	1636332000	33.98
cash and cash equivalents	987665000	673476000	46.65
short term investments	21695000	160186000	-86.46
long term investments	0	0	NaN
total current assets	2676032000	2191542000	22.11
total non current assets	7227539000	6732766000	7.35
total current liabilities	5067433000	5001578000	1.32
total non current liabilities	2643837000	2286398000	15.63
common stock	543495000	543495000	0.00
retained earnings	-3924470000	-4470489000	12.21
total debt	4093051000	3677095000	11.31

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 9,904 million in 2023 from 8,924 million in 2022 representing a change of 10.97%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 2,192 million in 2023 from 1,636 million in 2022 representing a change of 33.98%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 988 million in 2023 from 673 million in 2022 representing a change of 46.65%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 2,676 million in 2023 from 2,192 million in 2022 representing a change of 22.11%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to -3,924 million in 2023 from -4,470 million in 2022 representing a change of 12.21%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 7,711 million in 2023 from 7,288 million in 2022 representing a change of 5.81%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 22 million in 2023 from 160 million in 2022 representing a change of -86.46%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 5,067 million in 2023 from 5,002 million in 2022 representing a change of 1.32%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 4,093 million in 2023 from 3,677 million in 2022 representing a change of 11.31%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	9979760000	9979760000	0.00
total liabilities	7401503000	7401503000	0.00
total equity	2578257000	2578257000	0.00
cash and cash equivalents	649449000	649449000	0.00
short term investments	16053999	16053999	0.00
long term investments	0	0	NaN
total current assets	2396562000	2396562000	0.00
total non current assets	7583198000	7583198000	0.00
total current liabilities	4902950000	4902950000	0.00
total non current liabilities	2498553000	2498553000	0.00
common stock	543495000	543495000	0.00
retained earnings	-3538169000	-3538169000	0.00
total debt	4054089000	3790618000	6.95

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 4,054 million in 2024Q2 from 3,791 million in 2024Q1 representing a change of 6.95%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	194187000	518494000	-62.55
operating cash flow	1047921000	981620000	6.75
free cash flow	36477000	-383672000	109.51
capital expenditure	-1011444000	-1365292000	25.92
depreciation and amortization	359233000	277603000	29.41
deferred income tax	33089000	0	NaN
stock based compensation	2587000	12517000	-79.33
accounts payables	283769000	161406000	75.81
inventory	-22336000	-340640000	93.44
acquisitions net	-15000000	0	NaN
investments in property plant and equipment	-473674000	-1365292000	65.31
net cash used for investing activites	-1004437000	-1358731000	26.08
debt repayment	364666000	1073563000	-66.03
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	144431000	858016000	-83.17
cash at end of period	867663000	673476000	28.83
accounts receivables	-283769000	-161406000	-75.81
cash at beginning of period	673476000	154982000	334.55

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 194 million in 2023 from 518 million in 2022 representing a change of -62.55%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -1,011 million in 2023 from -1,365 million in 2022 representing a change of 25.92%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 33 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 284 million in 2023 from 161 million in 2022 representing a change of 75.81%. This indicates that the company has increased its outstanding obligations to its suppliers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 1,048 million in 2023 from 982 million in 2022 representing a change of 6.75%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 36 million in 2023 from -384 million in 2022 representing a change of 109.51%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 3 million in 2023 from 13 million in 2022 representing a change of -79.33%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -284 million in 2023 from -161 million in 2022 representing a change of -75.81%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	125631500	125631500	0.00
free cash flow	73789000	73789000	0.00
capital expenditure	-51842500	-51842500	0.00
depreciation and amortization	86304000	86304000	0.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-29240500	-29240500	0.00
accounts payables	0	0	NaN
inventory	-18659500	-18659500	0.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-51842500	-51842500	0.00
net cash used for investing activites	-331827500	-331827500	0.00
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-72907500	-72907500	0.00
net change in cash	-276876000	-276876000	0.00
cash at end of period	-276876000	590787000	-146.87
cash at beginning of period	0	867663000	-100.00

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	9.88	5.93	66.59
net income per share	1	-1.28	177.96
operating cash flow per share	1.92	1.81	5.97
free cash flow per share	0.07	-0.71	109.44
cash per share	1.85	1.54	20.19
book value per share	4.02	3.02	33.00
tangible book value per share	-1.96	-4.97	60.66
shareholders equity per share	4.02	3.02	33.00
interest debt per share	7.7	6.98	10.31
market cap	7243108024.78	6126143292.99	18.23
enterprise value	10348494024.78	9129762292.99	13.35
pe ratio	13.27	-8.81	250.55
price to sales ratio	1.34	1.91	-29.55
pocfratio	6.91	6.24	10.75
pfcf ratio	198.57	-15.97	1343.59
pb ratio	3.3	3.74	-11.75
ptb ratio	3.3	3.74	-11.75
ev to sales	1.92	2.84	-32.46
enterprise value over ebitda	11.36	-29.39	138.63
ev to operating cash flow	9.88	9.3	6.18
ev to free cash flow	283.7	-23.8	1292.23
earnings yield	0.08	-0.11	166.42
free cash flow yield	0.01	-0.06	108.04
debt to equity	1.87	2.25	-16.92
debt to assets	0.41	0.41	0.31
net debt to ebitda	3.41	-9.67	135.24
current ratio	0.53	0.44	20.52
interest coverage	5.71	-5.55	202.95
income quality	1.84	-1.41	230.05
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.07	0.11	-35.40
research and ddevelopement to revenue	0.21	0.43	-52.20
intangibles to total assets	0.33	0.49	-32.18
capex to operating cash flow	0.97	1.39	-30.60
capex to revenue	0.19	0.42	-55.86
capex to depreciation	2.82	4.92	-42.75
stock based compensation to revenue	0.0	0.0	-87.68
graham number	9.5	9.33	1.82
roic	0.08	-0.09	186.96
return on tangible assets	0.08	-0.15	154.29
graham net net	-10.67	-10.58	-0.84
working capital	-2391401000	-2810036000	14.90
tangible asset value	-1068284000	-2695951000	60.37
net current asset value	-5035238000	-5096434000	1.20
invested capital	3521838000	3752118000	-6.14
average receivables	559987500	375625000	49.08
average payables	629183500	548511000	14.71
average inventory	757335500	588712000	28.64
days sales outstanding	44.96	51.72	-13.08
days payables outstanding	134.72	308.36	-56.31
days of inventory on hand	187.27	327.27	-42.78
receivables turnover	8.12	7.06	15.04
payables turnover	2.71	1.18	128.89
inventory turnover	1.95	1.12	74.76
roe	0.25	-0.42	158.62
capex per share	1.85	2.52	-26.46

• Positive

  ROE: Return on Equity (ROE) increased to 0.25 on 2023-12-31 from -0.42 on 2022-12-31, representing a change of 158.62%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 13.27 on 2023-12-31 from -8.81 on 2022-12-31, representing a change of 250.55%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio increased to 0.53 on 2023-12-31 from 0.44 on 2022-12-31, representing a change of 20.52%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Debt-to-Equity Ratio:

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
2696.HK
calendar year	2024	2024	NaN
revenue per share	2.52	2.52	0.00
net income per share	0.36	0.36	0.00
operating cash flow per share	0.23	0.23	0.00
free cash flow per share	0.14	0.14	0.00
cash per share	1.22	1.22	0.00
book value per share	4.74	4.74	0.00
tangible book value per share	-4.12	-4.12	0.00
shareholders equity per share	4.74	4.74	0.00
interest debt per share	7.45	6.97	6.95
market cap	11564584209.34	7186003840.64	60.93
enterprise value	14969224209.34	10327172840.64	44.95
pe ratio	14.97	9.3	60.93
price to sales ratio	8.42	5.23	60.93
pocfratio	92.05	57.2	60.93
pfcf ratio	156.73	97.39	60.93
pb ratio	4.49	2.79	60.93
ptb ratio	4.49	2.79	60.93
ev to sales	10.9	7.52	44.95
enterprise value over ebitda	51.06	35.23	44.95
ev to operating cash flow	119.15	82.2	44.95
ev to free cash flow	202.87	139.96	44.95
earnings yield	0.02	0.03	-37.86
free cash flow yield	0.01	0.01	-37.86
debt to equity	1.57	1.47	6.95
debt to assets	0.41	0.38	6.95
net debt to ebitda	11.61	10.71	8.39
current ratio	0.49	0.49	0.00
interest coverage	0	0	NaN
income quality	0.65	0.65	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.06	0.06	0.00
research and ddevelopement to revenue	0.18	0.18	0.00
intangibles to total assets	0.48	0.48	0.00
capex to operating cash flow	0.41	0.41	0.00
capex to revenue	0.04	0.04	0.00
capex to depreciation	0.6	0.6	0.00
stock based compensation to revenue	0	0	NaN
graham number	6.15	6.15	0.00
roic	0.03	0.03	0.00
return on tangible assets	0.04	0.04	0.00
graham net net	-10.57	-10.57	0.00
working capital	-2506388000	-2506388000	0.00
tangible asset value	-2241602000	-2241602000	0.00
net current asset value	-5004941000	-5004941000	0.00
invested capital	5030405000	5030405000	0.00
average receivables	788861000	394430500	100.00
average payables	617145000	580980000	6.22
average inventory	783331000	770345000	1.69
days sales outstanding	51.71	51.71	0.00
days payables outstanding	147.05	147.05	0.00
days of inventory on hand	186.65	186.65	0.00
receivables turnover	1.74	1.74	0.00
payables turnover	0.61	0.61	0.00
inventory turnover	0.48	0.48	0.00
roe	0.07	0.07	0.00
capex per share	0.1	0.1	0.00

• ROE:

  Debt-to-Equity Ratio:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 14.97 on 2024-06-30 Q2 from 9.30 on 2024-03-31 Q1, representing a change of 60.93%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio decreased to 0.49 on 2024-06-30 Q2 from 0.49 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None